Savient Pharmaceuticals (United States)

Alternate names: Bio-Technology General Corp, Savient Pharmaceuticals, Savient Pharmaceuticals, Inc.
ROR: 02yrbkt92
OpenAlex ID: I4405280449
2007 · Kenneth W. Lyles, Cathleen S. Colón-Emeric, et al. · New England Journal of Medicine · 2,171
2012 · Bo Jin, Tao Sun, et al. · Clinical and Developmental Immunology · 224
2009 · MICHAEL A. BECKER, H. RALPH SCHUMACHER, et al. · The Journal of Rheumatology · 195
2002 · Shing-shing Yeh, Bernadette DeGuzman, et al. · CHEST Journal · 137
2010 · Richard A. Brook, Anna Forsythe, et al. · Current Medical Research and Opinion · 124
2012 · Michael A Becker, Herbert S B Baraf, et al. · Annals of the Rheumatic Diseases · 109
2010 · N.L. Edwards, J.S. Sundy, et al. · Journal of Medical Economics · 100
2011 · Nicola Dalbeth, Cameron Schauer, et al. · Annals of the Rheumatic Diseases · 81
2014 · Herbert S. B. Baraf, Robert A. Yood, et al. · JCR Journal of Clinical Rheumatology · 67
2008 · Herbert S. B. Baraf, Alan K. Matsumoto, et al. · Arthritis & Rheumatism · 46
2004 · Cathleen S. Colón-Emeric, John Caminis, et al. · Current Medical Research and Opinion · 44
1999 · Sarah Fox-Wheeler, Linda Heller, et al. · PEDIATRICS · 43
Works count: 39
Citation count: 5,110
Year
Topic
Type